Clinical Value of Positron Emission Tomography with FDG for Recurrent Ovarian Cancer

Authors:

Abstract
OBJECTIVE. Recurrence is often a major problem for patients who have undergone surgery for ovarian cancer. This prospective study was undertaken to evaluate the clinical contribution of positron emission tomography (PET) using 18F-fluorodeoxyglucose (FDG) for recurrent ovarian cancer.SUBJECTS AND METHODS. Twenty-four women who had undergone surgery or chemoradiotherapy for histopathologically proven ovarian cancer were enrolled in this study. Ovarian cancer was thought to have recurred in 12 of these women because of evidence on conventional imaging modalities or tumor marker measurements (group A). Clinical findings for the remaining 12 women showed them to be disease-free (group B). PET findings for the women were compared with the final diagnoses obtained by histopathology or by clinical follow-up. The clinical contribution of PET was assessed by evaluating whether PET yielded information complementing the findings of conventional modalities and by examining its impact on treatment.RESULTS. PET gave va...

This publication has 22 references indexed in Scilit: